Resolving resolvins.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Human leukocytes selectively convert 4Proceedings of the National Academy of Sciences of the United States of America · 2021
   Article
2. Resolvin D3 multi-level proresolving actions are host protective during infection.Prostaglandins, leukotrienes, and essential fatty acids · 2018
   Article
3. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.Molecular aspects of medicine · 2017
   Review

Corrections and comments

• Comment on
  Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents.2013

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract